MXCTMaxCyte, Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $1.18 · now $1.18 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, MXCT has typically landed between $0.87 and $1.48 — a range of −26.5% to +25.3% from the issuance price $1.18.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,267 overlapping 1 month windows · 2021-07-30 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($1.18) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where MXCT has typically landed a month from the 2026-09-16 close of $1.18 — the range is history, not a prediction.

$0.8678worst · -26.5%$1.48best · +25.3%
  • now $1.18 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.13 (-3.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $0.9978–$1.27
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $0.8678–$1.48
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,267 windows spanning 2021-07-30 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2026-01-02−47.4%−47.4%+0.0%
2026-01-07−46.5%−46.5%+0.0%
2026-01-12−46.3%−46.3%+0.0%
3 best
2023-10-30+64.5%+0.0%+64.5%
2023-10-27+61.4%+0.0%+61.4%
2023-10-31+60.5%+0.0%+64.5%

1,267 overlapping windows · 2021-07-30 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
60%
−10.9%
n=5
Feb
20%
−12.1%
n=5
Mar
40%
−6.2%
n=5
Apr
60%
−0.8%
n=5
May
40%
+1.9%
n=5
Jun
60%
−0.8%
n=5
Jul
40%
+3.0%
n=5
Aug
17%
−8.7%
n=6
Sep
33%
−2.5%
n=6
Oct
20%
−3.4%
n=5
Nov
40%
+9.9%
n=5
Dec
40%
−0.5%
n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$2$12026-03-17: 1 insider sale, $8K — Swirsky Douglas J2025-08-13: 5 insider purchases, $480K — Erck Stanley C, DOUGLAS RICHARD, Masoud Maher, Brooke William W …2025-08: 5 open-market purchases, $480K2026-03: 1 open-market sale, $8K↑ buys↓ salesdirector Swirsky Douglas J — Sale on 2026-03-17, filed 2 days after the tradedirector Erck Stanley C — Purchase on 2025-08-13, filed same daydirector DOUGLAS RICHARD — Purchase on 2025-08-13, filed same daydirector Masoud Maher — Purchase on 2025-08-13, filed same daydirector Brooke William W — Purchase on 2025-08-13, filed same daydirector Swirsky Douglas J — Purchase on 2025-08-13, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-03-17Swirsky Douglas JdirectorSale10,142 @ $0.81$8K−6.3% of holding−3.0%+34.5%151,669Form 4 · filed 2 days after the trade
2025-08-13Erck Stanley CdirectorPurchase100,000 @ $1.37$137K+33.5% of holding+3.1%−53.1%398,328Form 4 · filed same day
2025-08-13DOUGLAS RICHARDdirectorPurchase80,000 @ $1.39$111K+53.1% of holding+3.1%−53.1%230,577Form 4 · filed same day
2025-08-13Masoud MaherdirectorPurchase75,000 @ $1.37$103K+75.0% of holding+3.1%−53.1%175,000Form 4 · filed same day
2025-08-13Brooke William WdirectorPurchase50,000 @ $1.29$65K+49.6% of holding+3.1%−53.1%150,879Form 4 · filed same day
2025-08-13Swirsky Douglas JdirectorPurchase50,000 @ $1.29$65K+44.7% of holding+3.1%−53.1%161,811Form 4 · filed same day
2025-06-25Hemrajani RekhadirectorSale10,684 @ $2.09$22K−21.1% of holding−4.0%−44.5%39,893Form 4 · filed 63 days after the trade
2025-03-18Swirsky Douglas JdirectorSale6,939 @ $3.18$22K−5.8% of holding−14.0%−71.2%111,811Form 4 · filed 2 days after the trade
2025-03-18Soleymannezhad AliofficerSale1,211 @ $3.18$4K−2.0% of holding−14.0%−71.2%59,439Form 4 · filed 2 days after the trade
2025-03-18Sandoval David I.officerSale353 @ $3.18$1K−0.5% of holding−14.0%−71.2%64,219Form 4 · filed 2 days after the trade
2025-01-27Johnston John JosephdirectorSale3,000 @ $4.64$14K−2.1% of holding−20.9%−59.7%141,950Form 4 · filed 2 days after the trade
2025-01-13Sandoval David I.officerSale4,466 @ $4.54$20K−9.7% of holding−18.2%−64.8%41,447Form 4 · filed 1 day after the trade
2024-12-26Johnston John JosephdirectorSale3,000 @ $4.01$12K−2.1% of holding+13.9%−50.0%141,950Form 4 · filed 4 days after the trade
2024-12-09Johnston John JosephdirectorSale2,495 @ $3.79$9K−1.7% of holding+9.2%−46.0%141,950Form 4 · filed 1 day after the trade
2024-12-06Johnston John JosephdirectorSale505 @ $3.70$2K−0.4% of holding+29.6%−35.7%141,950Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

55 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-06-17Al-Wakeel Yasir B.directorAward / grant30,42180,998Form 4
2026-06-17Al-Wakeel Yasir B.directorAward / grant49,57949,579Form 4
2026-06-17BALTHROP PATRICK JdirectorAward / grant30,42180,998Form 4
2026-06-17BALTHROP PATRICK JdirectorAward / grant49,57949,579Form 4
2026-06-17Brooke William WdirectorAward / grant30,421181,300Form 4
2026-06-17Brooke William WdirectorAward / grant49,57949,579Form 4
2026-06-17Collins CynthiadirectorAward / grant30,421111,310Form 4
2026-06-17Collins CynthiadirectorAward / grant49,57949,579Form 4
2026-06-17DOUGLAS RICHARDdirectorAward / grant30,421260,998Form 4
2026-06-17DOUGLAS RICHARDdirectorAward / grant49,57949,579Form 4
2026-06-17Erck Stanley CdirectorAward / grant30,421428,749Form 4
2026-06-17Erck Stanley CdirectorAward / grant49,57949,579Form 4
2026-06-17Hemrajani RekhadirectorAward / grant30,42170,314Form 4
2026-06-17Hemrajani RekhadirectorAward / grant49,57949,579Form 4
2026-06-17Johnston John JosephdirectorAward / grant30,421201,581Form 4
2026-06-17Johnston John JosephdirectorAward / grant49,57949,579Form 4
2026-04-15Ahuja ParmeetofficerAward / grant187,500187,500Form 4
2026-03-30Ahuja ParmeetofficerAward / grant375,000375,000Form 4
2026-03-27Masoud MaherdirectorAward / grant300,000475,000Form 4
2026-03-27Masoud MaherdirectorAward / grant600,000600,000Form 4
2025-06-18Johnston John JosephdirectorAward / grant29,210171,160Form 4
2025-06-18Johnston John JosephdirectorAward / grant50,79050,790Form 4
2025-06-18Al-Wakeel Yasir B.directorAward / grant29,21050,577Form 4
2025-06-18Al-Wakeel Yasir B.directorAward / grant50,79050,790Form 4
2025-06-18BALTHROP PATRICK JdirectorAward / grant29,21050,577Form 4
2025-06-18BALTHROP PATRICK JdirectorAward / grant50,79050,790Form 4
2025-06-18Brooke William WdirectorAward / grant29,210100,879Form 4
2025-06-18Brooke William WdirectorAward / grant50,79050,790Form 4
2025-06-18Collins CynthiadirectorAward / grant29,21080,889Form 4
2025-06-18Collins CynthiadirectorAward / grant50,79050,790Form 4
2025-06-18DOUGLAS RICHARDdirectorAward / grant29,210150,577Form 4
2025-06-18DOUGLAS RICHARDdirectorAward / grant50,79050,790Form 4
2025-06-18Erck Stanley CdirectorAward / grant29,210298,328Form 4
2025-06-18Erck Stanley CdirectorAward / grant50,79050,790Form 4
2025-06-18Hemrajani RekhadirectorAward / grant29,21050,577Form 4
2025-06-18Hemrajani RekhadirectorAward / grant50,79050,790Form 4
2025-03-14Sandoval David I.officerAward / grant92,50092,500Form 4
2025-03-14Sandoval David I.officerAward / grant23,12564,572Form 4
2025-03-14Swirsky Douglas JdirectorAward / grant37,500118,750Form 4
2025-03-14Swirsky Douglas JdirectorAward / grant150,000150,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.